Ursula Gundert‐Remy

12.9k total citations
190 papers, 4.4k citations indexed

About

Ursula Gundert‐Remy is a scholar working on Pharmacology, Health, Toxicology and Mutagenesis and Pharmacology. According to data from OpenAlex, Ursula Gundert‐Remy has authored 190 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Pharmacology, 36 papers in Health, Toxicology and Mutagenesis and 33 papers in Pharmacology. Recurrent topics in Ursula Gundert‐Remy's work include Pharmacogenetics and Drug Metabolism (29 papers), Effects and risks of endocrine disrupting chemicals (26 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Ursula Gundert‐Remy is often cited by papers focused on Pharmacogenetics and Drug Metabolism (29 papers), Effects and risks of endocrine disrupting chemicals (26 papers) and Antibiotics Pharmacokinetics and Efficacy (22 papers). Ursula Gundert‐Remy collaborates with scholars based in Germany, United Kingdom and Italy. Ursula Gundert‐Remy's co-authors include Hans Mielke, Lennart Iselius, G. Alv�n, P Bechtel, Ulrike Bernauer, E. Weber, Falko Partosch, Alan R. Boobis, Olavi Pelkonen and Jan G. Hengstler and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Science of The Total Environment and Hepatology.

In The Last Decade

Ursula Gundert‐Remy

184 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ursula Gundert‐Remy Germany 35 1.1k 931 710 477 472 190 4.4k
A.G. Renwick United Kingdom 38 1.1k 1.0× 528 0.6× 702 1.0× 228 0.5× 194 0.4× 122 4.2k
John A. Timbrell United Kingdom 34 910 0.9× 1.5k 1.6× 1.9k 2.6× 449 0.9× 647 1.4× 125 6.5k
Babasaheb Sonawane United States 32 1.4k 1.3× 497 0.5× 796 1.1× 216 0.5× 285 0.6× 81 3.8k
Jeffrey W. Fisher United States 40 2.4k 2.2× 535 0.6× 464 0.7× 245 0.5× 207 0.4× 162 4.5k
Vishal S. Vaidya United States 48 818 0.8× 631 0.7× 2.1k 3.0× 364 0.8× 444 0.9× 104 8.8k
A. G. Renwick United Kingdom 33 1.1k 1.0× 356 0.4× 946 1.3× 190 0.4× 199 0.4× 80 4.3k
A. Jay Gandolfi United States 46 1.9k 1.8× 1.3k 1.4× 1.8k 2.5× 213 0.4× 538 1.1× 268 7.1k
Kannan Krishnan Canada 38 2.2k 2.1× 519 0.6× 399 0.6× 220 0.5× 161 0.3× 143 4.3k
Sami Haddad Canada 35 1.2k 1.1× 536 0.6× 327 0.5× 118 0.2× 430 0.9× 117 3.0k
James V. Bruckner United States 32 1.1k 1.0× 695 0.7× 345 0.5× 165 0.3× 235 0.5× 119 3.1k

Countries citing papers authored by Ursula Gundert‐Remy

Since Specialization
Citations

This map shows the geographic impact of Ursula Gundert‐Remy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ursula Gundert‐Remy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ursula Gundert‐Remy more than expected).

Fields of papers citing papers by Ursula Gundert‐Remy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ursula Gundert‐Remy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ursula Gundert‐Remy. The network helps show where Ursula Gundert‐Remy may publish in the future.

Co-authorship network of co-authors of Ursula Gundert‐Remy

This figure shows the co-authorship network connecting the top 25 collaborators of Ursula Gundert‐Remy. A scholar is included among the top collaborators of Ursula Gundert‐Remy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ursula Gundert‐Remy. Ursula Gundert‐Remy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Batke, Monika, Georg Damm, Heidi Foth, et al.. (2025). Fluoride intake during pregnancy: calculation of realistic exposure scenarios for individual risk assessment. Archives of Toxicology. 99(12). 4931–4940.
2.
Mielke, Hans, Engi Algharably, & Ursula Gundert‐Remy. (2025). 5-Fluorouracil Toxicity: Revisiting the Relevance of Pharmacokinetic Parameters. Pharmaceuticals. 18(5). 653–653.
3.
Algharably, Engi, Emma Di Consiglio, Emanuela Testai, Reinhold Kreutz, & Ursula Gundert‐Remy. (2021). Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro–in vivo extrapolation. Archives of Toxicology. 95(4). 1433–1442. 8 indexed citations
4.
Partosch, Falko, Hans Mielke, Ralf Stahlmann, et al.. (2014). Internal threshold of toxicological concern values: enabling route-to-route extrapolation. Archives of Toxicology. 89(6). 941–948. 31 indexed citations
5.
Stammschulte, Thomas, et al.. (2014). Unerwartete Blutungskomplikationen im Zusammenhang mit Celecoxib. Der Anaesthesist. 63(12). 958–960. 5 indexed citations
6.
Mielke, Hans, Falko Partosch, & Ursula Gundert‐Remy. (2011). The contribution of dermal exposure to the internal exposure of bisphenol A in man. Toxicology Letters. 204(2-3). 190–198. 62 indexed citations
7.
Schott, Gisela, et al.. (2010). Finanzierung von Arzneimittelstudien durch pharmazeutische Unternehmen und die Folgen. Nanotechnology. 26(33). 335702–335702. 3 indexed citations
8.
Dahl, Svein G., Leon Aarons, Ursula Gundert‐Remy, et al.. (2009). Incorporating Physiological and Biochemical Mechanisms into Pharmacokinetic–Pharmacodynamic Models: A Conceptual Framework*. Basic & Clinical Pharmacology & Toxicology. 106(1). 2–12. 23 indexed citations
9.
Lahl, Uwe & Ursula Gundert‐Remy. (2008). The Use of (Q)SAR Methods in the Context of REACH. Toxicology Mechanisms and Methods. 18(2-3). 149–158. 20 indexed citations
10.
Paál, Krisztina, et al.. (2006). Improved detection of detoxifying enzymes in rat liver crude extract by optimisation of the standard two-dimensional gel electrophoresis. OpenAgrar. 3 indexed citations
11.
Appel, Kurt, et al.. (2006). Kann für Formaldehyd eine "sichere" Konzentration abgeleitet werden? - Analyse der Daten zur krebserzeugenden Wirkung. OpenAgrar. 3 indexed citations
12.
Oberemm, Axel, et al.. (2005). How can toxicogenomics inform risk assessment?. Toxicology and Applied Pharmacology. 207(2). 592–598. 43 indexed citations
13.
Gundert‐Remy, Ursula, Sandra Noack, Ulrike Bernauer, H Bröll, & Barbara Heinrich-Hirsch. (2004). Establishment of a rapid TaqMan((R))-assay for genotyping polymorphic alleles of cytochrome P450 enzymes in human tissue. Toxicology and Applied Pharmacology. 197(3). 255–255. 2 indexed citations
14.
Oberemm, Axel, et al.. (2003). Proteomic analysis of TCDD-mediated effects in marmoset liver and thymus. OpenAgrar. 1 indexed citations
15.
Heinrich-Hirsch, Barbara, et al.. (2003). Immunochemical determination of xenobiotic-metabolizing cytochrome P450 (P450) enzymes in human CD34+bone marrow stem cells. OpenAgrar. 1 indexed citations
16.
Kietzmann, Daniela, Thomas Bouillon, Kerstin Schwabe, et al.. (1997). Pharmacodynamic modelling of the analgesic effects of piritramide in postoperative patients. Acta Anaesthesiologica Scandinavica. 41(7). 888–894. 22 indexed citations
17.
Becker, Julia C., et al.. (1990). [Double blind biometric study on postoperative effects of analgesics].. PubMed. 45(1). 36–8. 4 indexed citations
18.
Gundert‐Remy, Ursula. (1982). [Clinical trials of drugs].. PubMed. 5(9). 266–74. 3 indexed citations
19.
Gundert‐Remy, Ursula, et al.. (1982). Altered hydroxylation rate of triamterene in patients with liver cirrhosis.. PubMed. 20(8). 353–7. 1 indexed citations
20.
Gundert‐Remy, Ursula, et al.. (1979). Plasma and urinary levels of triamterene and certain metabolites after oral administration to man. European Journal of Clinical Pharmacology. 16(1). 39–44. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.G. Renwick Breakdown of academic impact, for papers by John A. Timbrell Breakdown of academic impact, for papers by Babasaheb Sonawane Breakdown of academic impact, for papers by Jeffrey W. Fisher Breakdown of academic impact, for papers by Vishal S. Vaidya Breakdown of academic impact, for papers by A. G. Renwick Breakdown of academic impact, for papers by A. Jay Gandolfi Breakdown of academic impact, for papers by Kannan Krishnan Breakdown of academic impact, for papers by Sami Haddad Breakdown of academic impact, for papers by James V. Bruckner
Rankless by CCL
2026